Drug development is a very risky endeavor with long cycle-times and high attrition rates. Less than 1 in 20 preclinical candidate molecules reach the market to improve the lives of patients. Phase 2 shows the highest failure ... read more

There are numerous tools and technologies for formulation scientists to develop the optimal dosage form for a drug. As with many aspects of science, simply having the tools on hand is not enough. Experience plays a crucial ... read more

According to the popularly cited study from Tufts Center for the Study of Drug Development, it costs $2.6 billion to receive a drug approval.1 Despite the increased investments and revolutionary therapies brought to market... read more